Shenzhen Weiguang Biological Products Co Ltd Cash Flow-to-Debt Ratio
Shenzhen Weiguang Biological Products Co Ltd cash flow-to-debt ratio. Shenzhen Weiguang Biological Products Co Ltd (002880) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥51.60 Million could theoretically repay 0% of its total liabilities (CN¥1.04 Billion) in one year. Check Shenzhen Weiguang Biological Products Co total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shenzhen Weiguang Biological Products Co Ltd (2012–2025)
Cash flow-to-debt ratio of Shenzhen Weiguang Biological Products Co Ltd from 2012 to 2025. Historical debt coverage capacity for Shenzhen Weiguang Biological Products Co Ltd across 14 annual periods. Check 002880 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Shenzhen Weiguang Biological Products Co Ltd Cash Flow-to-Debt Ratio by Year (2012–2025)
Shenzhen Weiguang Biological Products Co Ltd cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Shenzhen Weiguang Biological Products Co Ltd. For the full cash flow conversion analysis, see Shenzhen Weiguang Biological Products Co (002880) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | CN¥263.18 Million | CN¥1.29 Billion | ▲ +20.4% |
| 2024 | 0.17x | CN¥177.77 Million | CN¥1.05 Billion | ▼ -64.7% |
| 2023 | 0.48x | CN¥397.94 Million | CN¥831.14 Million | ▲ +28179.0% |
| 2022 | 0.00x | CN¥1.20 Million | CN¥708.20 Million | ▼ -99.9% |
| 2021 | 1.15x | CN¥246.89 Million | CN¥215.23 Million | ▼ -19.9% |
| 2020 | 1.43x | CN¥303.96 Million | CN¥212.36 Million | ▲ +5.3% |
| 2019 | 1.36x | CN¥185.70 Million | CN¥136.64 Million | ▲ +109.6% |
| 2018 | 0.65x | CN¥99.54 Million | CN¥153.53 Million | ▲ +288.6% |
| 2017 | 0.17x | CN¥28.61 Million | CN¥171.52 Million | ▼ -46.8% |
| 2016 | 0.31x | CN¥126.41 Million | CN¥403.44 Million | ▼ -3.5% |
| 2015 | 0.32x | CN¥150.09 Million | CN¥462.25 Million | ▲ +11.5% |
| 2014 | 0.29x | CN¥134.17 Million | CN¥460.73 Million | ▲ +580.3% |
| 2013 | 0.04x | CN¥20.93 Million | CN¥488.91 Million | ▼ -80.4% |
| 2012 | 0.22x | CN¥115.88 Million | CN¥530.63 Million | — |